Metraipolis › archive › dc_f548275fe307

Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies — Europe PMC PMID:41568391

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41568391
DOI
10.3389/fonc.2025.1691518
License (as archived)
solo-consultazione
Archived
2026-11-07T00:57:59.589Z
SHA-256 of the archived text
b4a9eda6ed5a7d2e828b70b31a2b2e9fb3d52523bd80c437c02293832df626c0
Stable URL of this page
https://metraipolis.com/documento/dc_f548275fe307

How to cite

Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies — Europe PMC PMID:41568391 — Europe PMC (en), https://europepmc.org/article/MED/41568391 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f548275fe307 (Metraipolis archive dc_f548275fe307, sha256 b4a9eda6ed5a7d2e828b70b31a2b2e9fb3d52523bd80c437c02293832df626c0)
BibTeX
@misc{dcf548275fe307,
  title = {Ocular toxicities of targeted therapies and immunotherapies in hematologic malignancies — Europe PMC PMID:41568391},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41568391},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f548275fe307; sha256 b4a9eda6ed5a7d2e828b70b31a2b2e9fb3d52523bd80c437c02293832df626c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41568391. Agents can read the archived copy with the MCP tool read_document.